Crossmark

Commentary: Efficacy of Clorpactin in refractory bladder pain syndrome/interstitial cystitis: a randomized controlled trial

Crossref DOI link: https://doi.org/10.1007/s00192-021-04731-z

Published Online: 2021-03-11

Published Print: 2021-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Patel, Mittal https://orcid.org/0000-0002-3111-3257
License Information

Text and Data Mining valid from 2021-03-11

Version of Record valid from 2021-03-11
More Information

Article History

Received: 5 January 2021

Accepted: 9 February 2021

First Online: 11 March 2021

Free to read: This content has been made available to all.